novo nordisk ozempic news

Winding, fitful path to weight loss drug Ozempic

The winding, fitful path to weight loss drug Ozempic

Half a century of advancements in biomedical science paved the way for today's powerful weight-loss drugs like Ozempic—so what was that journey like for the scientists involved?

WPIX New York City, NY on MSN · 1h

The truth about ‘weight-loss’ drugs like Ozempic

Dr. Sue Decotiis, a board-certified weight loss specialist, joins PIX11 to discuss why “weight-loss” drugs such as Ozempic aren’t for everyone and the possible side effects of using these medications.

Minneapolis Star Tribune on MSN · 6h

Maker of Ozempic, Wegovy sues Minnesota clinic over knockoff weight-loss medication

One of the world’s largest drug manufacturers is suing a small east metro wellness center over the way it marketed and sold a compounded, off-brand version of its blockbuster weight-loss medications.

UPI · 1d

Cost of weight-loss drugs has many exploring sources beyond doctors

Many people are doing an end-run around their doctor's office, reaching out to potentially unreliable sources that promise to set them up with Wegovy, Zepbound and other weight-loss drugs.

Bernie Sanders, Ozempic

Yahoo · 1d

Bernie Sanders says Ozempic can be produced for less than $100 a month

Sen. Sanders claims that the CEOs of major generic drugmakers said they produce and sell Ozempic for less $100 a month.

U.S. News & World Report · 2d

US Senator Sanders Says Generic Drugmakers Could Sell Ozempic for Less Than $100/month

U.S. Senator Bernie Sanders said on Tuesday he received confirmation from major generic pharmaceutical companies that they could sell copycat versions of Novo Nordisk's diabetes drug Ozempic for less than $100 a month.

Quartz on MSN · 1d

Bernie Sanders says drugmakers could sell generic Ozempic for less than $100

Sen. Bernie Sanders said on Tuesday that CEOs at major generic pharma companies have told him that they are willing to sell a generic version of Ozempic for hundreds of dollars cheaper than the popular diabetes drug’s current list price.

1don MSN

Cheap Ozempic is coming: Cost could soon be slashed for millions of Americans, drugmaker confirms — here’s how

Get the skinny on this. Novo Nordisk, the Danish pharmaceutical company that manufactures Ozempic, said that it is “very ...

Seeking Alpha1h

Novo Nordisk: The Street Is Not Seeing The Growth Acceleration Potential

However, Novo Nordisk is in a peculiar situation where it cannot produce enough of its GLP-1 products Wegovy and ...

Novo Says Ozempic ‘Very Likely’ Target for Next US Price Cut

Ozempic, the blockbuster diabetes shot made by Novo Nordisk A/S, is “very likely” to be one of the next drugs targeted for a ...

JD Supra1d

Ozempic Lawsuit Update: New Study Links Semaglutides to Increased Risk of Vision Loss

More plaintiffs are continuing to join the diabetes drug Ozempic lawsuits against Novo Nordisk; and, until a couple of weeks ...

Novo says Ozempic 'very likely' to be on 2027 Medicare negotiation list, Bloomberg News reports

Danish drugmaker Novo Nordisk expects its diabetes drug Ozempic will "very likely" be on the U.S. government's 2027 list of ...

Novo Nordisk Just Took a $530 Million Step Onto Moderna's Turf. Here's What It Means for Both Stocks

Founded in 1993, The Motley Fool is a financial services company dedicated to making the world smarter, happier, and richer. The Motley Fool reaches millions of people every month through our premium ...

Novo Nordisk and Nanovation sign $600m deal in rare and cardiometabolic diseases

NanoVation will receive $600m in upfront cash and potential milestone payments, as well as tiered royalties on future product ...

Multiple Strong Catalysts And Attractive Valuation Make Novo Nordisk A Buy

Novo Nordisk has multiple, strong upcoming, positive catalysts, related to its GLP-1 weight-loss drugs, Ozempic and Wegovy.

Novo Nordisk’s New Obesity Pill Beats Wegovy In Early Trial

Data from an early stage clinical trial suggests Novo Nordisk’s new weight loss pill amycretin could produce greater and more ...

Vermont Business Magazine3d

Ahead of Novo Nordisk hearing, 250 clinicians demand affordable access to Ozempic and Wegovy

Novo Nordisk CEO Lars Jørgensen will testify about the high cost of Ozempic and Wegovy at an upcoming HELP Committee hearing on September 24th.

Some results have been hidden because they may be inaccessible to you

Show inaccessible results

Related topics